Valerie W. Rusch

Top papers

• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  William D. Travis, Élisabeth Brambilla, Masayuki Noguchi, et al.·2011·Journal of Thoracic Oncology
  ↗ 4,822OA
• The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

  Peter Goldstraw, Kari Chansky, John Crowley, et al.·2016·Journal of Thoracic Oncology
  ↗ 4,592OA
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

  William Pao, Vincent A. Miller, Maureen F. Zakowski, et al.·2004·Proceedings of the National Academy of Sciences
  ↗ 4,337OA
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  Peter Goldstraw, John Crowley, Kari Chansky, et al.·2007·Journal of Thoracic Oncology
  ↗ 3,671
• CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

  Andy Trotti, A. D. Colevas, A. Setser, et al.·2003·Seminars in Radiation Oncology
  ↗ 2,564
• Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

  Patrick M. Forde, Jamie E. Chaft, Kellie N. Smith, et al.·2018·New England Journal of Medicine
  ↗ 2,113OA
• <i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib

  James Bean, Cameron Brennan, Jin‐Yuan Shih, et al.·2007·Proceedings of the National Academy of Sciences
  ↗ 1,585
• Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

  Kathy S. Albain, Ruth Swann, Valerie W. Rusch, et al.·2009·The Lancet
  ↗ 1,463
• Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

  Kerby Shedden, David G. Beer, Kerby Shedden, et al.·2008·Nature Medicine
  ↗ 1,242OA
• The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer

  Valerie W. Rusch, Hisao Asamura, Hirokazu Watanabe, et al.·2009·Journal of Thoracic Oncology
  ↗ 1,191OA
• Characterizing the cancer genome in lung adenocarcinoma

  Barbara A. Weir, Michele Sue‐Ann Woo, Gad Getz, et al.·2007·Nature
  ↗ 1,118OA
• Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

  Akihiko Yoshizawa, Noriko Motoi, Gregory J. Riely, et al.·2011·Modern Pathology
  ↗ 992